How much revenue does Hemagen Diagnostics make?

Hemagen Diagnostics reported $4.04 million in revenue for fiscal year 2012, down 21.4% from $5.14 million in fiscal year 2011.

What companies are similar to Hemagen Diagnostics?

Listed companies of a similar size in the same industry (multi-therapeutic drug manufacturing) include Maven Brands Inc. (TRLFF), Rebus Holdings, Inc. (RBSH), Curative Biosciences, Inc. (CBDX), Sienna Biopharmaceuticals, Inc. (SNNAQ).

Hemagen Diagnostics, Inc. (HMGN) Stock

About Hemagen Diagnostics, Inc.

Hemagen Diagnostics, Inc. provides human and veterinary diagnostic services worldwide. The company develops, manufactures, and markets VIRGO, a human clinical diagnostic line of immunoassays for the diagnosis of autoimmune and infectious diseases, and acute phase proteins. Its proprietary test kits are used to aid in the diagnosis of certain autoimmune and infectious diseases. It also provides hum...

At a glance

Hemagen Diagnostics reported revenue of $4.04 million for fiscal year 2012, down 21.4% from fiscal year 2011, and net income of -$907,315.

Figures from company filings; latest fiscal year ended September 30, 2012.

No profile data available.

Disclaimer: This analysis is for informational and educational purposes only and does not constitute financial, investment, tax, or legal advice. Data may be incomplete, delayed, or contain inaccuracies. Consult with a qualified financial advisor before making any investment decisions.